Literature DB >> 21295457

Dyspnoea and the brain.

Mari Herigstad1, Anja Hayen, Katja Wiech, Kyle T S Pattinson.   

Abstract

Chronic dyspnoea is a devastating symptom that debilitates millions of people worldwide. It causes a large burden on both patient and carer, and significant costs to society and health services. Treatment options are limited. Much effort has been directed at optimising lung function and improving exercise capacity, however, the brain mechanisms underlying dyspnoea perception have received less attention. In this review, we focus on cognitive and affective aspects of dyspnoea and discuss how novel neuroimaging methods can provide quantitative measures of these subjective sensations. We draw parallels with the more advanced field of chronic pain, and explain some of the challenges faced when imaging dyspnoea. To date, brain mechanisms of dyspnoea have been investigated in a handful of studies by a limited number of authors. These have found consistent activation in the insular cortex, the anterior cingulate cortex and the amygdala. Novel neuroimaging methods and an improved understanding of perceptual mechanisms underlying dyspnoea now position us to transform dyspnoea research. Future research should investigate how brain regions associated with dyspnoea interact, as well as accurately correlate this neuronal activation with reliable behavioural measures. A better understanding of the brain processes underlying dyspnoea perception will lead to new therapies that will improve quality of life for a very large group of patients.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21295457     DOI: 10.1016/j.rmed.2010.12.022

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  30 in total

Review 1.  Old and new tools to assess dyspnea in the hospitalized patient.

Authors:  Barbro Kjellström; Martje H L van der Wal
Journal:  Curr Heart Fail Rep       Date:  2013-09

Review 2.  New insights on the role of the insular cortex and habenula in OSA.

Authors:  Ming-Xian Li; Chao-Ying Yan; Shao Wang
Journal:  Sleep Breath       Date:  2015-05-10       Impact factor: 2.816

3.  Intensity cut-points for the Respiratory Distress Observation Scale.

Authors:  Margaret L Campbell; Thomas N Templin
Journal:  Palliat Med       Date:  2015-01-29       Impact factor: 4.762

4.  Injection of L-glutamate into the insular cortex produces sleep apnea and serotonin reduction in rats.

Authors:  Li Cui; Jing-Hua Wang; Min Wang; Min Huang; Chun-Yong Wang; Huan Xia; Jian-guo Xu; Ming-Xian Li; Shao Wang
Journal:  Sleep Breath       Date:  2011-09-27       Impact factor: 2.816

Review 5.  [Management of refractory breathlessness in patients with advanced disease].

Authors:  C Bausewein
Journal:  Internist (Berl)       Date:  2016-10       Impact factor: 0.743

6.  [Dyspnea. From the concept up to diagnostics].

Authors:  R Ewert; S Gläser
Journal:  Internist (Berl)       Date:  2015-08       Impact factor: 0.743

7.  The cortical connectivity of the periaqueductal gray and the conditioned response to the threat of breathlessness.

Authors:  Olivia K Faull; Kyle Ts Pattinson
Journal:  Elife       Date:  2017-02-17       Impact factor: 8.140

8.  Objects of safety and imprisonment: Breathless patients' use of medical objects in a palliative setting.

Authors:  Kate Binnie; Coreen McGuire; Havi Carel
Journal:  J Mater Cult       Date:  2020-06-12

9.  Systemic corticosteroids for the management of cancer-related breathlessness (dyspnoea) in adults.

Authors:  Alison Haywood; Jacqueline Duc; Phillip Good; Sohil Khan; Kirsty Rickett; Petra Vayne-Bossert; Janet R Hardy
Journal:  Cochrane Database Syst Rev       Date:  2019-02-20

10.  The effects of altered intrathoracic pressure on resting cerebral blood flow and its response to visual stimulation.

Authors:  Anja Hayen; Mari Herigstad; Michael Kelly; Thomas W Okell; Kevin Murphy; Richard G Wise; Kyle T S Pattinson
Journal:  Neuroimage       Date:  2012-10-27       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.